2,107 results on '"Stone, John H"'
Search Results
2. IgG4-Related Disease
3. Reactive Arthritis
4. Regional Musculoskeletal Problems
5. Epidemiology of Gout
6. Rheumatoid Vasculitis
7. Less Common Vasculitides
8. Giant Cell Arteritis and Polymyalgia Rheumatica
9. Thromboangiitis Obliterans
10. Cryoglobulinemia
11. Polyarteritis Nodosa
12. Eosinophilic Granulomatosis with Polyangiitis
13. Microscopic Polyangiitis
14. Granulomatosis with Polyangiitis
15. Vasculitic Neuropathy
16. Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology–European League Against Rheumatism classification criteria
17. Fibrotic phenotype of IgG4-related disease
18. Real-world application of the pediatric Glucocorticoid Toxicity Index in childhood-onset lupus
19. Granzyme K– and amphiregulin-expressing cytotoxic T cells and activated extrafollicular B cells are potential drivers of IgG4-related disease
20. A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
21. Qualitative interviews to support development of a patient-reported companion measure to the Glucocorticoid Toxicity Index
22. Diagnosis and management of ANCA-associated vasculitis
23. Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study
24. Eosinophilic Angiocentric Fibrosis of the Orbit: A Clinicopathologic Review of 6 Novel Cases With Review of the Literature
25. Assessment of patient-reported symptoms and distress in IgG4-related disease (IgG4-RD): Development, clinical validation, and content validation of the IgG4-RD Symptom Severity Index
26. Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial
27. The Glucocorticoid Toxicity Index-Metabolic Domains, an abridged version of the Glucocorticoid Toxicity Index: post-hoc analysis of data from the ADVOCATE trial
28. Extrafollicular IgD−CD27−CXCR5−CD11c− DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19
29. IgG4-related disease as a variable-vessel vasculitis: A case series of 13 patients with medium-sized coronary artery involvement
30. IgG4-Related Disease Overview: Pathology, Clinical Picture, and Treatment
31. Glucocorticoid Toxicity Index scores by domain in patients with antineutrophil cytoplasmic antibody-associated vasculitis treated with avacopan versus standard prednisone taper: post-hoc analysis of data from the ADVOCATE trial
32. Development and Validation of a Simulation Model for Treatment to Maintain Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
33. Multimodality Imaging Features of Immunoglobulin G4–related Vessel Involvement
34. Celebrating progress in the vasculitides, old and new
35. The Effects of Treatment on Body Mass Index in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial
36. The pediatric glucocorticoid toxicity index
37. IgG4‐related disease: Association with a rare gene variant expressed in cytotoxic T cells
38. Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials
39. IgG4-related diseases of the digestive tract
40. Cytotoxic CD8+ T cells may be drivers of tissue destruction in Sjögren’s syndrome
41. Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort study
42. Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study
43. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis
44. Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial
45. Quantification of Glucocorticoid-Associated Morbidity in Severe Asthma Using the Glucocorticoid Toxicity Index
46. Lifetime Allergy Symptoms in IgG4‐Related Disease: A Case–Control Study
47. Pathophysiology-Based Approaches to Treatment
48. Neurologic Complications of Immunoglobulin G4-Related Disease (IgG4-RD)
49. Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race
50. What do the IgG4-related disease (IgG4-RD) classification criteria tell us about the nature of IgG4-RD?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.